Physician profile
Darrell D Prins
NPI 1174520902
$1,773.16
in general payments reported to CMS, 2019-2025
13 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $16.20 · 2021: $12.92 · 2022: $820 · 2023: $466 · 2024: $43.10 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583 · Travel and Lodging: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.85 |
| Travel and Lodging | $189.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,167.40 | 2022-2024 | |
| Nevro Corp. | $144.72 | 2022 | |
| Abbvie INC. | $124.20 | 2019 | |
| Kerecis Limited | $114.52 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $76.64 | 2025 | Restrata Wound Matrix |
| Wright Medical Technology, INC. | $28.28 | 2019 | |
| Fusion Orthopedics USA, LLC | $22.25 | 2025 | |
| Solventum Corporation | $20.99 | 2025 | V.A.C. Veraflo |
| Stryker Corporation | $16.58 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $16.20 | 2020 | |
| Smith+Nephew, INC. | $15.46 | 2025 | Grafix Pl |
| Molnlycke Health Care US, LLC | $13.00 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Kci USA, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Prins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.